doi: 10.1093/bja/aeu025.
Open letter to the Executive Director of the European Medicines Agency concerning the licensing of hydroxyethyl starch solutions for fluid resuscitation
- PMID: 24535531
- DOI: 10.1093/bja/aeu025
Item in Clipboard
Open letter to the Executive Director of the European Medicines Agency concerning the licensing of hydroxyethyl starch solutions for fluid resuscitation
Br J Anaesth.
2014 Mar.
Free article
No abstract available
Comment in
-
Counter statement to open letter to the Executive Director of the European Medicines Agency concerning the licensing of hydroxyethyl starch solutions for fluid resuscitation.Br J Anaesth. 2014 Jul;113(1):194-5. doi: 10.1093/bja/aeu217. Br J Anaesth. 2014. PMID: 24942721 No abstract available.
Similar articles
-
Counter statement to open letter to the Executive Director of the European Medicines Agency concerning the licensing of hydroxyethyl starch solutions for fluid resuscitation.Br J Anaesth. 2014 Jul;113(1):194-5. doi: 10.1093/bja/aeu217. Br J Anaesth. 2014. PMID: 24942721 No abstract available.
-
Open Letter to the Executive Director of the European Medicines Agency concerning the licensing of hydroxyethyl starch solutions for fluid resuscitation.Acta Anaesthesiol Scand. 2014 Mar;58(3):365-70. doi: 10.1111/aas.12241. Acta Anaesthesiol Scand. 2014. PMID: 25237699 No abstract available.
-
Should hydroxyethyl starch solutions be totally banned?Crit Care. 2013 Oct 1;17(5):193. doi: 10.1186/cc13027. Crit Care. 2013. PMID: 24083341 Free PMC article. Review.
-
Starch solutions in Australia: the empire strikes back.Crit Care Resusc. 2013 Dec;15(4):253-4. Crit Care Resusc. 2013. PMID: 24289503 No abstract available.
-
Why hydroxyethyl starch solutions should NOT be banned from the operating room.Anaesthesiol Intensive Ther. 2014 Nov-Dec;46(5):336-41. doi: 10.5603/AIT.2014.0057. Anaesthesiol Intensive Ther. 2014. PMID: 25432553 Review.
Cited by
-
Intraoperative hydroxyethyl starch 70/0.5 administration may increase postoperative bleeding: a retrospective cohort study.J Anesth. 2017 Jun;31(3):330-336. doi: 10.1007/s00540-017-2334-2. Epub 2017 Mar 24. J Anesth. 2017. PMID: 28341919
-
Comparison of hydroxyethyl starch regulatory summaries from the Food and Drug Administration and the European Medicines Agency.J Pharm Policy Pract. 2017 Mar 21;10:12. doi: 10.1186/s40545-016-0090-6. eCollection 2017. J Pharm Policy Pract. 2017. PMID: 28331624 Free PMC article.
-
Use of perioperative hydroxyethyl starch 6% and albumin 5% in elective joint arthroplasty and association with adverse outcomes: a retrospective population based analysis.BMJ. 2015 Mar 27;350:h1567. doi: 10.1136/bmj.h1567. BMJ. 2015. PMID: 25817299 Free PMC article.
-
Time and Type of Administered Fluids during Cesarean Section Might Not Matter for Hemodynamic Outcomes, but There Are Significant Patient Safety Concerns Regarding Colloid Use in Parturients. Comment on Theodoraki et al. Colloid Preload versus Crystalloid Co-Load in the Setting of Norepinephrine Infusion during Cesarean Section: Time and Type of Administered Fluids Do Not Matter. J. Clin. Med. 2023, 12, 1333.J Clin Med. 2023 Jul 18;12(14):4753. doi: 10.3390/jcm12144753. J Clin Med. 2023. PMID: 37510867 Free PMC article.
-
Concerns over use of hydroxyethyl starch solutions.BMJ. 2014 Nov 10;349:g5981. doi: 10.1136/bmj.g5981. BMJ. 2014. PMID: 25385352 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
